4Day C, James O. Steatohepatitis: A tale of two ''hits''? Gastroenterology, 1998, 114: 842-845.
5Marchesini G, Brizi M, Morselli- Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance.Am J Med, 1999, 107: 450-455.
6Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology, 2002,35: 373-379.
7Uygun A, Kadayifei A, Yesiloua Z, et al. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroen terol, 2000, 95: 3584-3588.
8Guebre- Xabier M, Yang SQ, Lin HZ, et al. Altered hepatic lymphocyte subpopulations in obesity- related murine fatty livers: potential mechanism for sensitization to liver damage.Hepatology, 2000, 31: 633-640.
9Cortez- Pinto H, Chatham J, Chacko VP, et al. Alterations in liver ATP Homeostasis in human nonalcoholic steatohepatitis:A pilot study. JAMA, 1999, 282: 1659-1664.
10Angulo P, Deach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.Hepatology, 1999,30: 1356-1362.
